Frost & Sullivan Awards Groundbreaking Microemboli Detection System from Luna Innovations
03 Outubro 2006 - 9:45AM
PR Newswire (US)
Recipient of the 2006 Patient Monitoring Technology of the Year
Award PALO ALTO, Calif., Oct. 3 /PRNewswire/ -- Frost &
Sullivan selected Luna Innovations Incorporated (NASDAQ:LUNA) as
the recipient of the 2006 Patient Monitoring Technology of the Year
Award for the innovative design and development of the Embolus
Detection and Classification (EDAC(TM)) QUANTIFIER, a
groundbreaking blood circuit microemboli detection system. EDAC(TM)
QUANTIFIER is a noninvasive, pc-based medical device that uses
quantitative ultrasound technology to count emboli in ex-vivo blood
circuits in real-time. Employing highly sophisticated algorithms,
the system detects individual microemboli at rates over 1000 per
second. This provides cardiothoracic surgeons, perfusionists and
anesthesiologists with an accurate rate of emboli in the blood
circuit. Emboli can take the form of solid matter or air bubbles
that can enter the blood stream during invasive medical procedures
such as a cardio pulmonary bypass surgery. While gas embolism is a
known complication of various invasive procedures, the consequences
of gas microemboli, also known as microbubbles, are not well
understood and are usually overlooked in daily practice. The
techniques available for the detection of air embolism are
predominantly aimed at the venous circulation in the anesthesia
setting. However, these methods do not allow the exclusion of
embolism in all patients with intermediate or high clinical
suspicion of the disease. "The EDAC QUANTIFIER could prove to be
the ultimate solution for microemboli detection in extracorporeal
procedures where the conventional detection methods fail to be
efficient or accurate," says Frost & Sullivan Research Analyst
Mike Arani. "This device can rapidly identify and classify
individual emboli in real-time." Unlike conventional devices that
can only detect emboli in venous circulation, the EDAC system can
perform microemboli monitoring in both venous and arterial blood
streams. Additionally, this device allows perfusionists to identify
the existence of these microbubbles, thus enabling perfusionists to
potentially eliminate them at the source. One of the most
significant advantages of the EDAC system is its ability to
accurately detect very small emboli or microemboli that otherwise
go unidentified by the current systems. "Luna Innovations has been
able to achieve extraordinary success by aligning customer needs
and target markets with applicable technologies," notes Arani. "The
company recognized the need for more accurate and reliable
microemboli detection in the large cardiopulmonary bypass surgery
market, and then intelligently modified and remolded the available
algorithms to produce a well-balanced, innovative and marketable
solution." The potential market impact of the EDAC QUANTIFIER
device becomes clear when the large number of cardiopulmonary
bypass surgeries performed annually in the United States is
considered. Frost & Sullivan believes that once Luna
Innovations receives FDA clearance for the use of the EDAC
QUANTIFIER device in cardiopulmonary bypass surgeries, this product
will present itself as one of the necessary and essential patient
monitoring devices within most operating rooms. Each year Frost
& Sullivan presents this Award to a company that has
demonstrated technological superiority within its industry. The
Award recognizes the ability of the company to successfully develop
and introduce new technology, formulate a well-designed product
family and make significant product performance contributions to
the industry. Frost & Sullivan Best Practices Awards recognize
companies in a variety of regional and global markets for
demonstrating outstanding achievement and superior performance in
areas such as leadership, technological innovation, customer
service and strategic product development. Industry analysts
compare market participants and measure performance through
in-depth interviews, analysis and extensive secondary research in
order to identify best practices in the industry. For more info
about the EDAC QUANTIFIER please visit
http://www.lunamedicalproducts.com/ . About Luna Innovations Luna
Innovations Incorporated (NASDAQ:LUNA) researches, develops and
commercializes innovative technologies in molecular technology and
sensing solutions. Luna Innovations accelerates the process of
bringing new and innovative products to market by focusing on
technologies that can fulfill identified market needs and then
takes these technologies from the applied research stage through
commercialization. Luna's unique medical products are designed to
help identify complications accurately, quickly and non-invasively
so medical professionals can proceed with the appropriate form of
treatment. Since its inception, Luna Innovations has successfully
developed products for the energy, telecommunications, life
sciences and defense industries. Headquartered in Roanoke,
Virginia, the company has research, development and manufacturing
facilities in Blacksburg, Charlottesville, Hampton and Danville,
Virginia and a sales office in McLean, Virginia. Additional
information can be found at http://www.lunainnovations.com/ . About
Frost & Sullivan Frost & Sullivan, a global growth
consulting company, has been partnering with clients to support the
development of innovative strategies for more than 40 years. The
company's industry expertise integrates growth consulting, growth
partnership services and corporate management training to identify
and develop opportunities. Frost & Sullivan serves an extensive
clientele that includes Global 1000 companies, emerging companies
and the investment community by providing comprehensive industry
coverage that reflects a unique global perspective and combines
ongoing analysis of markets, technologies, econometrics and
demographics. For more information, visit
http://www.awards.frost.com/ or
http://www.patientmonitoring.frost.com/ Contact: Stacie Jones
210.247.2450 DATASOURCE: Frost & Sullivan CONTACT: Stacie Jones
of Frost & Sullivan, +1-210-247-2450, or Web site:
http://www.frost.com/ http://www.patientmonitoring.frost.com/
http://www.awards.frost.com/ http://www.lunainnovations.com/
http://www.lunamedicalproducts.com/
Copyright
Luna Innovations (NASDAQ:LUNA)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Luna Innovations (NASDAQ:LUNA)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024